Association Between Different Versions of the Model for End-Stage Liver Disease Score and Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Association Between Different Versions of the Model for End-Stage Liver Disease Score and Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention

Published:2021-12-21 Issue: Volume: Page:
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

He Hao-ming¹,He Chen²,You Zhe-bin³,Zhang Si-cheng¹,Lin Xue-qin¹,Luo Man-qing²,Lin Mao-qing¹,Zhang Li-wei²,Guo Yan-song²,Lin Kai-yang¹

Affiliation:

1. Fujian Provincial Key Laboratory of Cardiovascular Disease, Fujian Cardiovascular Institute, Fujian Provincial Center for Geriatrics, Fujian Clinical Medical Research Center for Cardiovascular Diseases

2. Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital

3. Department of Geriatric Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Provincial Center for Geriatrics

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-21-0816/_pdf

Reference35 articles.

1. 1. Weisbord SD, Palevsky PM, Kaufman JS, Wu H, Androsenko M, Ferguson RE, et al. Contrast-associated acute kidney injury and serious adverse outcomes following angiography. J Am Coll Cardiol 2020; 75: 1311–1320.

2. 2. Neyra JA, Shah S, Mooney R, Jacobsen G, Yee J, Novak JE. Contrast-induced acute kidney injury following coronary angiography: A cohort study of hospitalized patients with or without chronic kidney disease. Nephrol Dial Transplant 2013; 28: 1463–1471.

3. 3. Aubry P, Brillet G, Catella L, Schmidt A, Bénard S. Outcomes, risk factors and health burden of contrast-induced acute kidney injury: An observational study of one million hospitalizations with image-guided cardiovascular procedures. BMC Nephrol 2016; 17: 167.

4. 4. Alqahtani F, Balla S, AlHajji M, Chaudhary F, Albeiruti R, Kawsara A, et al. Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis. Catheter Cardiovasc Interv 2020; 96: 802–810.

5. 5. Lu DY, Steitieh D, Feldman DN, Cheung JW, Wong SC, Halazun H, et al. Impact of cirrhosis on 90-day outcomes after percutaneous coronary intervention (from a nationwide database). Am J Cardiol 2020; 125: 1295–1304.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Modified Model for End-Stage Liver Disease Score in Patients Undergoing Isolated Tricuspid Valve Replacement;Frontiers in Cardiovascular Medicine;2022-07-01